James B. Hall

1.7k total citations
44 papers, 1.2k citations indexed

About

James B. Hall is a scholar working on Reproductive Medicine, Surgery and Epidemiology. According to data from OpenAlex, James B. Hall has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 8 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in James B. Hall's work include Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Cervical Cancer and HPV Research (5 papers). James B. Hall is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Cervical Cancer and HPV Research (5 papers). James B. Hall collaborates with scholars based in United States, Australia and United Kingdom. James B. Hall's co-authors include Robert V. Higgins, R. Wendel Naumann, W. R. Adam, Linda F. Carson, Linda Van Le, Maurie Markman, Sheldon Weiner, Mark E. Baker, Valerie L. Ashton and Daniel L. Spitz and has published in prestigious journals such as Physical Review Letters, Journal of Clinical Oncology and Journal of Molecular Biology.

In The Last Decade

James B. Hall

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James B. Hall United States 18 334 312 283 242 213 44 1.2k
Hugh R. K. Barber United States 21 421 1.3× 350 1.1× 374 1.3× 295 1.2× 146 0.7× 84 1.2k
C. N. Hudson United Kingdom 18 289 0.9× 129 0.4× 276 1.0× 258 1.1× 198 0.9× 41 920
Carolyn M. Johnston United States 16 346 1.0× 298 1.0× 299 1.1× 129 0.5× 132 0.6× 33 1.1k
Britt Erickson United States 21 519 1.6× 395 1.3× 436 1.5× 289 1.2× 340 1.6× 147 1.7k
Jesse C. Crow United Kingdom 21 167 0.5× 136 0.4× 140 0.5× 298 1.2× 395 1.9× 46 1.2k
C. A. Joslin United Kingdom 21 143 0.4× 355 1.1× 289 1.0× 228 0.9× 264 1.2× 56 1.3k
Heiner Müller Germany 17 178 0.5× 275 0.9× 240 0.8× 294 1.2× 72 0.3× 49 1.2k
Monique Bertrand Canada 18 243 0.7× 231 0.7× 213 0.8× 200 0.8× 399 1.9× 83 1.2k
Michael J. Worley United States 17 404 1.2× 245 0.8× 367 1.3× 243 1.0× 173 0.8× 65 1.2k
C. W. E. Redman United Kingdom 22 559 1.7× 348 1.1× 502 1.8× 487 2.0× 460 2.2× 58 1.6k

Countries citing papers authored by James B. Hall

Since Specialization
Citations

This map shows the geographic impact of James B. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Hall more than expected).

Fields of papers citing papers by James B. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Hall. The network helps show where James B. Hall may publish in the future.

Co-authorship network of co-authors of James B. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Hall. A scholar is included among the top collaborators of James B. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Hall. James B. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vergote, Ignace, Neil J. Finkler, James B. Hall, et al.. (2010). Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer. International Journal of Gynecological Cancer. 20(5). 772–780. 47 indexed citations
3.
McKinney, Kimberly Q., et al.. (2006). Gene Expression Profiling of Ovarian Tissues for Determination of Molecular Pathways Reflective of Tumorigenesis. Journal of Molecular Biology. 358(1). 310–329. 11 indexed citations
4.
Seiden, Michael V., Howard A. Burris, Ursula A. Matulonis, et al.. (2006). A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies. Gynecologic Oncology. 104(3). 727–731. 97 indexed citations
5.
Seiden, Michael V., H. A. Burris, U. Matulonis, et al.. (2005). A phase II Trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody in subjects with heavily treated and platinum-resistant advanced Müllerian malignancies. Journal of Clinical Oncology. 23(16_suppl). 3151–3151. 8 indexed citations
6.
Chan, Stephen, Alan N. Gordon, Robert E. Coleman, et al.. (2003). A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma. Cancer Immunology Immunotherapy. 52(4). 243–248. 43 indexed citations
7.
Higgins, Robert V., R. Wendel Naumann, James B. Hall, & M. Haake. (2003). Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecologic Oncology. 89(3). 499–503. 31 indexed citations
8.
Hall, James B., et al.. (2002). Classification and management of USDI Bureau of Land Management's riparian and wetland sites in eastern and southern Idaho. Biodiversity Heritage Library (Smithsonian Institution). 1 indexed citations
9.
Markman, Maurie, James B. Hall, Daniel L. Spitz, et al.. (2002). Phase II Trial of Weekly Single-Agent Paclitaxel in Platinum/Paclitaxel-Refractory Ovarian Cancer. Journal of Clinical Oncology. 20(9). 2365–2369. 178 indexed citations
10.
Naumann, R. Wendel, et al.. (2000). Sexual Dysfunction Following Vulvectomy. Gynecologic Oncology. 77(1). 73–77. 115 indexed citations
11.
Price, Douglas K., et al.. (2000). The Phosphoprotein Op18/Stathmin is Differentially Expressed in Ovarian Cancer. Cancer Investigation. 18(8). 722–730. 68 indexed citations
12.
Naumann, R. Wendel, Robert V. Higgins, & James B. Hall. (1999). The Use of Adjuvant Radiation Therapy by Members of the Society of Gynecologic Oncologists. Gynecologic Oncology. 75(1). 4–9. 36 indexed citations
13.
Higgins, Robert V., et al.. (1999). Is Age a Barrier to the Aggressive Treatment of Ovarian Cancer with Paclitaxel and Carboplatin?. Gynecologic Oncology. 75(3). 464–467. 18 indexed citations
14.
Higgins, Robert V., James B. Hall, & Sherry Laurent. (1997). Primary care by obstetricians and gynecologists: Attitudes of the members of The South Atlantic Association of Obstetricians and Gynecologists. American Journal of Obstetrics and Gynecology. 177(2). 311–318. 14 indexed citations
15.
Higgins, Robert V., et al.. (1997). Radiation Myelopathy after Chemotherapy and Radiation Therapy for Fallopian Tube Carcinoma. Gynecologic Oncology. 64(2). 285–287. 4 indexed citations
16.
Alvarez, Ronald D., C. William Helm, Robert P. Edwards, et al.. (1994). Prospective Randomized Trial of LLETZ versus Laser Ablation in Patients with Cervical Intraepithelial Neoplasia. Gynecologic Oncology. 52(2). 175–179. 72 indexed citations
17.
Naumann, R. Wendel, Maria C. Bell, Ronald D. Alvarez, et al.. (1994). LLETZ Is an Acceptable Alternative to Diagnostic Cold-Knife Conization. Gynecologic Oncology. 55(2). 224–228. 56 indexed citations
18.
Hall, James B., et al.. (1986). Pseudoobstruction of the colon. Gynecologic Oncology. 24(3). 381–385. 4 indexed citations
19.
Hall, James B., et al.. (1972). The obnoxious weed Eupatorium odoratum (Compositae) in Ghana.. Ghana Journal of Agricultural Science. 5(1). 75–78. 17 indexed citations
20.
Hall, James B., et al.. (1972). Bremsstrahlung in α-α scattering. Physics Letters B. 41(2). 151–152. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugh R. K. Barber Breakdown of academic impact, for papers by C. N. Hudson Breakdown of academic impact, for papers by Carolyn M. Johnston Breakdown of academic impact, for papers by Britt Erickson Breakdown of academic impact, for papers by Jesse C. Crow Breakdown of academic impact, for papers by C. A. Joslin Breakdown of academic impact, for papers by Heiner Müller Breakdown of academic impact, for papers by Monique Bertrand Breakdown of academic impact, for papers by Michael J. Worley Breakdown of academic impact, for papers by C. W. E. Redman
Rankless by CCL
2026